Advances in biomarker development in acetaminophen toxicity.

Laura P James, Mitchell R McGill, Dean W Roberts, Jack A Hinson, William M Lee

Advances in clinical chemistry 2020

filter terms:

Acetaminophen liver injury is the most common cause of acute liver injury in the United States and several other countries. Diagnosis of acetaminophen-induced acute liver injury in the clinic is challenging due to the lack of validated and specific biomarkers. The following chapter provides an overview of recent advances evaluating candidate biomarkers in development for acetaminophen acute liver injury. Relationships of biomarkers to mechanisms of acetaminophen toxicity and their potential role in confirming the diagnosis and/or predicting evolving toxicity are addressed. © 2020 Elsevier Inc. All rights reserved.

Citation

Laura P James, Mitchell R McGill, Dean W Roberts, Jack A Hinson, William M Lee. Advances in biomarker development in acetaminophen toxicity. Advances in clinical chemistry. 2020;98:35-50